Composition for promoting therapeutic effect of retina degenerative disease gene and application thereof
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- BEIJING TONGREN HOSPITAL AFFILIATED TO CAPITAL MEDICAL UNIV
- Publication Date
- 2017-01-25
Smart Images

Figure 1 
Figure 2
Abstract
Description
technical field
[0001] The invention belongs to the field of biotechnology, and in particular relates to a composition for improving the effect of gene therapy for retinal degenerative diseases and an application thereof. Background technique
[0002] With the gradual control of optical-related eye diseases and inflammatory eye diseases, retinal neurodegenerative diseases have become the main cause of irreversible blindness in the world today, affecting the vision health of tens of millions of people. Such as retinitis pigmentosa (Retinitis Pigmentosa, RP), age-related macular degeneration (Age-related MacularDegeneration, AMD) and glaucoma. The pathological basis of visual function damage caused by such diseases is the irreversible damage of retinal neuron cells, and there is no effective treatment for this in clinic.
[0003] In recent years, the rapid progress of basic scientific research has brought new hope for the treatment of the above diseases; mainly including: gen...